Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascual Bordes

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Biomedical Science : IJBS|May 16, 2013
Sirolimus-Eluting Stents vs Uncoated Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery StenosisJosé Valencia, Vicente Mainar, Pascual Bordes, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 30, 2006
One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: results of a multicenter registryMarcelo Sanmartin, Jose Antonio Baz, Iñigo Lozano, et al.
International Journal of Cardiology|April 12, 2016
Evaluation of a 'color coding' system for the assessment of patients undergoing primary percutaneous coronary interventionJuan M Ruiz-Nodar, José M Gómez-Sansano, Emilio Galcerá, et al.
Revista Espanola De Cardiologia|July 26, 2011
[Minimum salvaged myocardium after rescue percutaneous coronary intervention: quantification by cardiac magnetic resonance]Juan M Ruiz-Nodar, Eloísa Feliu, Jessica Sánchez-Quiñones, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 10, 2018
MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and designSalvatore Brugaletta, Angel Cequier, Fernando Alfonso, et al.
European Heart Journal. Digital Health|January 23, 2025
Early discharge programme after transcatheter aortic valve implantation based on close follow-up supported by telemonitoring using artificial intelligence: the TeleTAVI studyMarta Herrero-Brocal, Raquel Samper, Jorge Riquelme, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 28, 2022
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trialLuis Ortega-Paz, Salvatore Brugaletta, Josep Gomez-Lara, et al.
Circulation|September 26, 2019
Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical TrialManel Sabaté, Fernando Alfonso, Angel Cequier, et al.
Lancet (London, England)|September 7, 2012
Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trialManel Sabate, Angel Cequier, Andrés Iñiguez, et al.
Revista Espanola De Cardiologia (English Ed.)|July 28, 2023
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trialFilippo Maria Verardi, Kamil Bujak, Paolo Tolomeo, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Biomedical Science : IJBS|May 16, 2013
Sirolimus-Eluting Stents vs Uncoated Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery StenosisJosé Valencia, Vicente Mainar, Pascual Bordes, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 30, 2006
One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: results of a multicenter registryMarcelo Sanmartin, Jose Antonio Baz, Iñigo Lozano, et al.
International Journal of Cardiology|April 12, 2016
Evaluation of a 'color coding' system for the assessment of patients undergoing primary percutaneous coronary interventionJuan M Ruiz-Nodar, José M Gómez-Sansano, Emilio Galcerá, et al.
Revista Espanola De Cardiologia|July 26, 2011
[Minimum salvaged myocardium after rescue percutaneous coronary intervention: quantification by cardiac magnetic resonance]Juan M Ruiz-Nodar, Eloísa Feliu, Jessica Sánchez-Quiñones, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 10, 2018
MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and designSalvatore Brugaletta, Angel Cequier, Fernando Alfonso, et al.
European Heart Journal. Digital Health|January 23, 2025
Early discharge programme after transcatheter aortic valve implantation based on close follow-up supported by telemonitoring using artificial intelligence: the TeleTAVI studyMarta Herrero-Brocal, Raquel Samper, Jorge Riquelme, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 28, 2022
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trialLuis Ortega-Paz, Salvatore Brugaletta, Josep Gomez-Lara, et al.
Circulation|September 26, 2019
Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical TrialManel Sabaté, Fernando Alfonso, Angel Cequier, et al.
Lancet (London, England)|September 7, 2012
Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trialManel Sabate, Angel Cequier, Andrés Iñiguez, et al.
Revista Espanola De Cardiologia (English Ed.)|July 28, 2023
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trialFilippo Maria Verardi, Kamil Bujak, Paolo Tolomeo, et al.
Pageof 4